Monsanto offers cash to U.S. farmers who
use controversial chemical
Send a link to a friend
[December 11, 2017]
By Tom Polansek
CHICAGO, Dec 11 (Reuters) - Monsanto Co
will give cash back to U.S. farmers who buy a weed killer that has been
linked to widespread crop damage, offering an incentive to apply its
product even as regulators in several U.S. states weigh restrictions on
its use.
The incentive to use XtendiMax with VaporGrip, a herbicide based on a
chemical known as dicamba, could refund farmers over half the sticker
price of the product in 2018 if they spray it on soybeans Monsanto
engineered to resist the weed killer, according to company data.
The United States faced an agricultural crisis this year caused by new
formulations of dicamba-based herbicides, which farmers and weed experts
say harmed crops because they evaporated and drifted away from where
they were sprayed.
Monsanto says XtendiMax is safe when properly applied. The company is
banking on the chemical and soybean seeds engineered to resist it,
called Xtend, to dominate soybean production in the United States, the
world’s second-largest exporter.
BASF SE and DowDuPont also sell versions of dicamba-based herbicides.
Monsanto's cash-back offer comes as federal and state regulators are
requiring training for farmers who plan to spray dicamba in 2018 and
limiting when it can be used. Weed specialists say the restrictions make
the chemical more costly and inconvenient to apply, but Monsanto's
incentive could help convince farmers to use it anyway.
"We believe cash-back incentives for using XtendiMax with VaporGrip
Technology better enable growers to use a management system that
represents the next level of weed control," said Ryan Rubischko,
Monsanto product manager.
XtendiMax costs about $11 per acre to buy, and Monsanto is offering $6
per acre in cash back to farmers when they apply it on Xtend soybeans
along with other approved herbicides, according to the company.

Monsanto competes against rivals including Bayer AG to sell genetically
modified soybean seeds and chemicals to farmers. Bayer is selling its
LibertyLink soybean brand, a main rival to Xtend, to BASF as part of a
deal to acquire Monsanto for $63.5 billion.
[to top of second column]
|

Monsanto also faces increasing government oversight.
This month, North Dakota said it planned to prohibit the use of
dicamba herbicides after June 30, 2018, and when temperatures top 85
degrees Fahrenheit in a bid to prevent the chemical from drifting
away from where it is sprayed.
Missouri said it intends to finalize restrictions on XtendiMax soon,
after banning sprayings of BASF's dicamba herbicide, called Engenia,
in 10 counties after June 1, 2018, and statewide after July 15,
2018.
Arkansas is close to prohibiting dicamba sprayings after April 15,
2018, the tightest limits yet, while Minnesota is also considering
restrictions.

The states are taking action after the U.S. Environmental Protection
Agency mandated special training for dicamba users for 2018,
requiring farmers to keep records proving they were complying with
label instructions.
"Utilizing the technology, the cost will go up because of these
changes," said Andrew Thostenson, a pesticide specialist for North
Dakota State University.
Monsanto predicts U.S. farmers will double plantings of Xtend
soybeans to about 40 million acres next year despite reports of crop
damage this past summer.
Farmers said its cash-back offer was designed to increase sales.
"I think they're just trying to buy more acres," Dan Henebry, an
Illinois farmer who plans to grow Xtend soybeans next year, said
about Monsanto. (Reporting by Tom Polansek; Editing by Andrew Hay)
[© 2017 Thomson Reuters. All rights
reserved.]
Copyright 2017 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed. |